{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:03:24Z","timestamp":1783353804742,"version":"3.54.6"},"reference-count":74,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences"},{"name":"CIFMS","award":["2021-I2M-1-003"],"award-info":[{"award-number":["2021-I2M-1-003"]}]},{"name":"CIFMS","award":["2022-I2M-C&T-A-015"],"award-info":[{"award-number":["2022-I2M-C&T-A-015"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170127"],"award-info":[{"award-number":["82170127"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2507802"],"award-info":[{"award-number":["2023YFC2507802"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300159"],"award-info":[{"award-number":["82300159"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Hematology"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/16078454.2025.2564511","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T12:52:14Z","timestamp":1759755134000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["The effectiveness and safety of various treatments for hemophilia in China: a literature review and evidence mapping"],"prefix":"10.1080","volume":"30","author":[{"given":"Yu","family":"Yang","sequence":"first","affiliation":[{"name":"Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Tianjin, People\u2019s Republic of China"]},{"name":"Tianjin Institutes of Health Science","place":["Tianjin, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Tianjin, People\u2019s Republic of China"]},{"name":"Tianjin Institutes of Health Science","place":["Tianjin, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Tianjin, People\u2019s Republic of China"]},{"name":"Tianjin Institutes of Health Science","place":["Tianjin, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Dong","sequence":"additional","affiliation":[{"name":"Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Tianjin, People\u2019s Republic of China"]},{"name":"Tianjin Institutes of Health Science","place":["Tianjin, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Sun","sequence":"additional","affiliation":[{"name":"Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Tianjin, People\u2019s Republic of China"]},{"name":"Tianjin Institutes of Health Science","place":["Tianjin, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Dai","sequence":"additional","affiliation":[{"name":"Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Tianjin, People\u2019s Republic of China"]},{"name":"Tianjin Institutes of Health Science","place":["Tianjin, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mankai","family":"Ju","sequence":"additional","affiliation":[{"name":"Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Tianjin, People\u2019s Republic of China"]},{"name":"Tianjin Institutes of Health Science","place":["Tianjin, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Tianjin, People\u2019s Republic of China"]},{"name":"Tianjin Institutes of Health Science","place":["Tianjin, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Tianjin, People\u2019s Republic of China"]},{"name":"Tianjin Institutes of Health Science","place":["Tianjin, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Tianjin, People\u2019s Republic of China"]},{"name":"Tianjin Institutes of Health Science","place":["Tianjin, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongfeng","family":"Fu","sequence":"additional","affiliation":[{"name":"Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Tianjin, People\u2019s Republic of China"]},{"name":"Tianjin Institutes of Health Science","place":["Tianjin, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Tianjin, People\u2019s Republic of China"]},{"name":"Tianjin Institutes of Health Science","place":["Tianjin, People\u2019s Republic of China"]},{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xue","sequence":"additional","affiliation":[{"name":"Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Tianjin, People\u2019s Republic of China"]},{"name":"Tianjin Institutes of Health Science","place":["Tianjin, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renchi","family":"Yang","sequence":"additional","affiliation":[{"name":"Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Tianjin, People\u2019s Republic of China"]},{"name":"Tianjin Institutes of Health Science","place":["Tianjin, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200106073442307"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.7326\/M19-1208"},{"issue":"02","key":"e_1_3_6_4_1","first-page":"89","article-title":"Report on diagnosis and treatment of hemophilia in China 2023","volume":"22","author":"Xue F","year":"2023","unstructured":"Xue F, Dai J, Chen L, et al. Report on diagnosis and treatment of hemophilia in China 2023. J Diago Concepts Pract. 2023;22(02):89\u2013115.","journal-title":"J Diago Concepts Pract"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2012.02890.x"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06949.x"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00278-x"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14046"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S441873"},{"key":"e_1_3_6_10_1","unstructured":"World Federation of Hemophilia Report on the Annual Global Survey. 2023. https:\/\/www1.wfh.org\/publications\/files\/pdf-2525.pdf. Accessed."},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14217"},{"issue":"4","key":"e_1_3_6_12_1","first-page":"265","article-title":"Chinese guidelines on the treatment of hemophilia (version 2020)","volume":"41","author":"Chinese Medical Association","year":"2020","unstructured":"Chinese Medical Association. Chinese guidelines on the treatment of hemophilia (version 2020). Zhonghua xue ye xue za zhi=Zhonghua xueyexue zazhi. 2020;41(4):265\u2013271.","journal-title":"Zhonghua xue ye xue za zhi=Zhonghua xueyexue zazhi"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12672"},{"issue":"3","key":"e_1_3_6_14_1","first-page":"207","article-title":"Comparison of efficacy of intermediate- and low-dose recombinant human coagulation factor VII prophylaxis in adult patients with severe hemophilia A","volume":"44","author":"Chen R","year":"2021","unstructured":"Chen R, Gao H, Zhou SQ, et al. Comparison of efficacy of intermediate- and low-dose recombinant human coagulation factor VII prophylaxis in adult patients with severe hemophilia A. Int J Blood Transfusion Hematol. 2021;44(3):207\u2013212.","journal-title":"Int J Blood Transfusion Hematol"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14665"},{"key":"e_1_3_6_16_1","unstructured":"Euctr BG. BAX 326 (recombinant Factor IX): a phase 1\/3 prospective controlled multicenter study evaluating pharmacokinetics efficacy safety and immunogenicity in previously treated patients with severe (FIX level\u2009<\u20091%) or Moderately Severe (FIX level\u2009=\u20092%) Hemophilia B \u2013 BAX 326 pivotal. 2010. Available from: https:\/\/trialsearchwhoint\/Trial2aspx?TrialID=EUCTR2009-016720-31-BG"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000000389"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14635"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2022.03.008"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14276"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2017.1310720"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ped4.12122"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12248"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12562"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14577"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2023.02.016"},{"issue":"03","key":"e_1_3_6_27_1","first-page":"186","article-title":"Efficacy of domestic four-factor prothrombin complex concentrate as bypassing agent in hemophilia A children with inhibitor during immune tolerance induction therapy \u2013 single center data analysis","volume":"32","author":"Li ZK","year":"2019","unstructured":"Li ZK, Chen ZP, Li G, et al. Efficacy of domestic four-factor prothrombin complex concentrate as bypassing agent in hemophilia A children with inhibitor during immune tolerance induction therapy \u2013 single center data analysis. J Clin Hematol. 2019;32(03):186\u2013189.","journal-title":"J Clin Hematol"},{"issue":"16","key":"e_1_3_6_28_1","first-page":"2406","article-title":"Comparison of efficacies of low-dose prophylaxis on children and adults with severe hemophilia A in China","volume":"37","author":"Li ZT","year":"2016","unstructured":"Li ZT, Yang H, Qiu SQ, et al. Comparison of efficacies of low-dose prophylaxis on children and adults with severe hemophilia A in China. Guangdong Med J. 2016;37(16):2406\u20132409.","journal-title":"Guangdong Med J"},{"issue":"4","key":"e_1_3_6_29_1","first-page":"398","article-title":"Low-dose tertiary prophylactic therapy for severe haemophilia A adults in a single medical center in Beijing area","volume":"37","author":"Lian XY","year":"2015","unstructured":"Lian XY, Li KX, Hua BL, et al. Low-dose tertiary prophylactic therapy for severe haemophilia A adults in a single medical center in Beijing area. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015;37(4):398\u2013401.","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.992267"},{"issue":"12","key":"e_1_3_6_31_1","first-page":"923","article-title":"Analysis of individualized primary prophylactic treatment of 19 cases of children with severe hemophilia A","volume":"54","author":"Liu GQ","year":"2016","unstructured":"Liu GQ, Tang L, Wu XY, et al. Analysis of individualized primary prophylactic treatment of 19 cases of children with severe hemophilia A. Chin J Pediatr. 2016;54(12):923\u2013926.","journal-title":"Chin J Pediatr"},{"issue":"5","key":"e_1_3_6_32_1","first-page":"404","article-title":"A phase III multi-center clinical trial on safety and efficacy of a domestic plasma derived factor IX for the treatment of patients with hemophilia B","volume":"39","author":"Liu W","year":"2018","unstructured":"Liu W, Fu RF, Zhou YW, et al. A phase III multi-center clinical trial on safety and efficacy of a domestic plasma derived factor IX for the treatment of patients with hemophilia B. Zhonghua xue ye xue za zhi=Zhonghua xueyexue zazhi. 2018;39(5):404\u2013407.","journal-title":"Zhonghua xue ye xue za zhi=Zhonghua xueyexue zazhi"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14016"},{"issue":"4","key":"e_1_3_6_34_1","first-page":"536","article-title":"Effect of FVIII doses on joint structure and function in adolescents with severe hemophilia A: mid-term results of a prospective cohort study","volume":"41","author":"Meng L","year":"2021","unstructured":"Meng L, Zhuang J, Sun X, et al. Effect of FVIII doses on joint structure and function in adolescents with severe hemophilia A: mid-term results of a prospective cohort study. Nan Fang Yi Ke Da Xue Xue Bao. 2021;41(4):536\u2013542.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"10","key":"e_1_3_6_35_1","first-page":"1391","article-title":"Breakthrough bleeding in adult patients with severe hemophilia A receiving low- and intermediate-dose FVIII for tertiary prophylaxis: characteristics and influencing factors","volume":"37","author":"Qiu SQ","year":"2017","unstructured":"Qiu SQ, Zhuang JM, Zhou X, et al. Breakthrough bleeding in adult patients with severe hemophilia A receiving low- and intermediate-dose FVIII for tertiary prophylaxis: characteristics and influencing factors. Nan Fang Yi Ke Da Xue Xue Bao. 2017;37(10):1391\u20131395.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"5","key":"e_1_3_6_36_1","first-page":"e374","article-title":"Evaluation of the safety and efficacy of recombinant factor IX (nonacog alfa) in minimally treated and previously treated Chinese patients with haemophilia B","volume":"18","author":"Renchi Y","year":"2012","unstructured":"Renchi Y, Zhao Y, Wang X, et al. Evaluation of the safety and efficacy of recombinant factor IX (nonacog alfa) in minimally treated and previously treated Chinese patients with haemophilia B. Haemophilia. 2012;18(5):e374\u20138.","journal-title":"Haemophilia"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01472.x"},{"issue":"10","key":"e_1_3_6_38_1","first-page":"1222","article-title":"Efficacy of short-term full-dose prophylaxis in adult Chinese patients with severe hemophilia A","volume":"38","author":"Sun X","year":"2018","unstructured":"Sun X, Zhuang J, Zhou X, et al. Efficacy of short-term full-dose prophylaxis in adult Chinese patients with severe hemophilia A. Nan Fang Yi Ke Da Xue Xue Bao. 2018;38(10):1222\u20131227.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14777"},{"key":"e_1_3_6_40_1","unstructured":"Tan QT. Clinical Analysis of Prophylaxis in Childhood Hemophilia A in Sichuan Province. Chin J Thromb Hemost. 2016;22(1):66\u201371."},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12552"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13198"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S243146"},{"issue":"7","key":"e_1_3_6_44_1","first-page":"632","article-title":"Long-term low-dose secondary prophylaxis for severe and moderate hemophilia children with arthropathy in China: a single-center observation study","volume":"34","author":"Wu R","year":"2013","unstructured":"Wu R, Wu X, Zhang N, et al. Long-term low-dose secondary prophylaxis for severe and moderate hemophilia children with arthropathy in China: a single-center observation study. Zhonghua Xue Ye Xue Za Zhi. 2013;34(7):632\u2013634.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14256"},{"issue":"03","key":"e_1_3_6_46_1","first-page":"131","article-title":"Study on long-term joint outcome of regular low dose prophylaxis in children with severe hemophilia A with magnetic resonance imaging score","volume":"24","author":"Wu YF","year":"2019","unstructured":"Wu YF, Xiao J, Li Z, et al. Study on long-term joint outcome of regular low dose prophylaxis in children with severe hemophilia A with magnetic resonance imaging score. J China Pediatr Blood Cancer. 2019;24(03):131\u2013135.","journal-title":"J China Pediatr Blood Cancer"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14652"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00113-2"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14350"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13751"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026077"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S241605"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1177\/1076029616679507"},{"issue":"1","key":"e_1_3_6_54_1","first-page":"38","article-title":"Analysis of the effects of low\/intermediate dose of coagulation factor VII on 30 adult patients with severe hemophilia A in a single center","volume":"44","author":"Yuan YH","year":"2023","unstructured":"Yuan YH, Xu PP, Xu YY, et al. Analysis of the effects of low\/intermediate dose of coagulation factor VII on 30 adult patients with severe hemophilia A in a single center. Zhonghua xue ye xue za zhi=Zhonghua xueyexue zazhi. 2023;44(1):38\u201342.","journal-title":"Zhonghua xue ye xue za zhi=Zhonghua xueyexue zazhi"},{"issue":"8","key":"e_1_3_6_55_1","first-page":"624","article-title":"A multi-center clinical observation on safety and efficacy of a plasma derived coagulator factor VII for treatment of patients with hemophilia A","volume":"55","author":"Zhang JH","year":"2016","unstructured":"Zhang JH, Dong CX, Zhang AR, et al. A multi-center clinical observation on safety and efficacy of a plasma derived coagulator factor VII for treatment of patients with hemophilia A. Zhonghua Nei Ke Za Zhi. 2016;55(8):624\u2013627.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02432.x"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02395.x"},{"issue":"17","key":"e_1_3_6_58_1","first-page":"2487","article-title":"Influence of third-generation full length recombinant human coagulation factor VII on hemorrhage in children with moderate-to-severe hemophilia A","volume":"40","author":"Zhao XL","year":"2019","unstructured":"Zhao XL, Wang XG, Song LL, et al. Influence of third-generation full length recombinant human coagulation factor VII on hemorrhage in children with moderate-to-severe hemophilia A. Guangdong Med J. 2019;40(17):2487\u20132490.","journal-title":"Guangdong Med J"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1177\/1076029621989811"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1080\/08880018.2017.1313921"},{"issue":"01","key":"e_1_3_6_61_1","first-page":"59","article-title":"Efficacy and safety of third-generation full length recombinant human coagulation factor VII in the prophylactic treatment of childhood patients with moderate-to-severe hemophilia A: a single center experience","volume":"32","author":"Zhou RF","year":"2017","unstructured":"Zhou RF, Li Q, Ou YJ, et al. Efficacy and safety of third-generation full length recombinant human coagulation factor VII in the prophylactic treatment of childhood patients with moderate-to-severe hemophilia A: a single center experience. J Chin Prac Pediatr. 2017;32(01):59\u201362.","journal-title":"J Chin Prac Pediatr"},{"issue":"04","key":"e_1_3_6_62_1","first-page":"496","article-title":"Prophylactic treatment with low- and intermediate-dose factor VII in children with severe hemophilia A: comprehensive evaluation of joint outcomes and correlation analysis","volume":"38","author":"Zhuang JM","year":"2018","unstructured":"Zhuang JM, Sun XY\u5b59, Zhou X, et al. Prophylactic treatment with low- and intermediate-dose factor VII in children with severe hemophilia A: comprehensive evaluation of joint outcomes and correlation analysis. J South Med Univ. 2018;38(04):496\u2013501.","journal-title":"J South Med Univ"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.15062"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04214.x"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14603"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-12-470898"},{"issue":"1","key":"e_1_3_6_67_1","first-page":"49","article-title":"Induction of immune tolerance in haemophilia A inhibitor patients by the \u2018bonn protocol\u2019: predictive parameter for therapy duration and outcome","volume":"77","author":"Oldenburg J","year":"1999","unstructured":"Oldenburg J, Schwaab R, Brackmann HH. Induction of immune tolerance in haemophilia A inhibitor patients by the \u2018bonn protocol\u2019: predictive parameter for therapy duration and outcome. Vox Sang. 1999;77(Suppl 1):49\u201354.","journal-title":"Vox Sang"},{"issue":"1","key":"e_1_3_6_68_1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000462145","article-title":"Low-dose immune tolerance therapy: the van creveld model","volume":"70","author":"Mauser-Bunschoten EP","year":"1996","unstructured":"Mauser-Bunschoten EP, Roosendaal G, van den Berg HM. Low-dose immune tolerance therapy: the van creveld model. Vox Sang. 1996;70(Suppl 1):66\u201367.","journal-title":"Vox Sang"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.00195.x"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13531"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12188"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-360594"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1305074"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2021.100852"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-019-00395-6"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/16078454.2025.2564511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T10:13:00Z","timestamp":1765188780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/16078454.2025.2564511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/16078454.2025.2564511"],"URL":"https:\/\/doi.org\/10.1080\/16078454.2025.2564511","relation":{},"ISSN":["1607-8454"],"issn-type":[{"value":"1607-8454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhem20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhem20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-05-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2564511"}}